Last Price
45.85
Today's Change
-2.622 (5.40%)
Day's Change
45.85 - 48.59
Trading Volume
27,774
Overview
Market Cap
297 Million
Shares Outstanding
6 Million
Avg Volume
234,414
Avg Price (50 Days)
30.36
Avg Price (200 Days)
15.67
PE Ratio
-2.49
EPS
-18.39
Earnings Announcement
11-Nov-2024
Previous Close
48.48
Open
47.78
Day's Range
45.67 - 48.5977
Year Range
6.08 - 92.0
Trading Volume
31,519
Price Change Highlight
1 Day Change
-5.70%
5 Day Change
-25.02%
1 Month Change
220.81%
3 Month Change
362.23%
6 Month Change
309.63%
Ytd Change
488.35%
1 Year Change
501.51%
3 Year Change
-87.39%
5 Year Change
-91.35%
10 Year Change
-91.35%
Max Change
-91.35%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer; and ITIL-306 to recognize folate receptor alpha (FOLR1) with indications, including gynecological, non-small cell lung cancer, renal caner, and others. The company was incorporated in 2018 and is headquartered in Dallas, Texas.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
CEO Morning Brief
2
CEO Morning Brief
3
4
CEO Morning Brief
5
CEO Morning Brief
OpenAI Lets Anyone Use Its New Voice Assistant in Third-party Apps
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
